pISSN 1226-6051
eISSN 2508-786X

Table. 3.

Table. 3.

Characteristics of adverse event reports on finasteride and all other drugs from 2013 to 2017

Characteristics Subcategory Report on finasteride (%) Report on all other drugs (%) p-value*
Gender Male 1,404 (98.46) 1,133,337 (42.54) <0.0001
Female 22 (1.54) 1,530,666 (57.46)
Unknown 0 (0.00) 0 (0.00)
Age (yr) 0-19 6 (0.42) 140,019 (5.26) <.0001
20-39 138 (9.68) 374,987 (14.08)
40-64 424 (29.73) 1,304,371 (48.96)
≥65 858 (60.17) 844,626 (31.71)
Unknown 0 (0.00) 0 (0.00)
Original reporter Clinician 719 (50.42) 1,279,475 (48.03) <.0001
Pharmacist 348 (24.40) 383,634 (14.40)
Consumers 252 (17.67) 80,734 (3.03)
Others 94 (6.59) 865,907 (32.50)
Unknown 13 (0.91) 54,253 (2.04)
Reporter Regional pharmacovigilance center 548 (38.43) 1,473,849 (55.32) <.0001
Manufacture 785 (55.05) 1,118,232 (41.98)
Medical institution 9 (0.63) 49,327 (1.85)
Pharmacist 5 (0.35) 3,289 (0.12)
Consumers 74 (5.19) 14,711 (0.55)
Others 5 (0.35) 4,583 (0.17)
Unknown 0 (0.00) 12 (0.00)
Report type Spontaneous report 807 (56.59) 1,592,487 (59.78) 0.0018
Research (including re-examination) 600 (42.08) 1,037,200 (38.93)
Literature 19 (1.33) 21,915 (0.82)
Others 0 (0.00) 12,391 (0.47)
Unknown 0 (0.00) 10 (0.00)
Total 1,426 (100) 2,664,003 (100)

*chi-square test

Korean J Clin Pharm 2021;31:324-31 https://doi.org/10.24304/kjcp.2021.31.4.324
© 2021 Korean J Clin Pharm